We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Merck’s attorneys issued subpoenas to editors from the New England Journal of Medicine (NEJM) to testify in the company’s upcoming Vioxx trials, the Associated Press reported.